967 related articles for article (PubMed ID: 18223535)
1. Oral lesions and immune reconstitution syndrome in HIV+/AIDS patients receiving highly active antiretroviral therapy. Epidemiological evidence.
Gaitan Cepeda LA; Ceballos Salobreña A; López Ortega K; Arzate Mora N; Jiménez Soriano Y
Med Oral Patol Oral Cir Bucal; 2008 Feb; 13(2):E85-93. PubMed ID: 18223535
[TBL] [Abstract][Full Text] [Related]
2. Oral manifestations after immune reconstitution in HIV patients on HAART.
Ortega KL; Ceballos-Salobreña A; Gaitán-Cepeda LA; Magalhães MG
Int J STD AIDS; 2008 May; 19(5):305-8. PubMed ID: 18482959
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes and immune reconstitution in 103 advanced AIDS patients undergoing 12-month highly active antiretroviral therapy.
Dai Y; Qiu ZF; Li TS; Han Y; Zuo LY; Xie J; Ma XJ; Liu ZY; Wang AX
Chin Med J (Engl); 2006 Oct; 119(20):1677-82. PubMed ID: 17097013
[TBL] [Abstract][Full Text] [Related]
4. Immune reconstitution inflammatory syndrome among HIV/AIDS patients during highly active antiretroviral therapy in Addis Ababa, Ethiopia.
Huruy K; Mulu A; Mengistu G; Shewa-Amare A; Akalu A; Kassu A; Andargie G; Elias D; Torben W
Jpn J Infect Dis; 2008 May; 61(3):205-9. PubMed ID: 18503170
[TBL] [Abstract][Full Text] [Related]
5. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
[TBL] [Abstract][Full Text] [Related]
6. Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study.
Nicolatou-Galitis O; Velegraki A; Paikos S; Economopoulou P; Stefaniotis T; Papanikolaou IS; Kordossis T
Oral Dis; 2004 May; 10(3):145-50. PubMed ID: 15089923
[TBL] [Abstract][Full Text] [Related]
7. Increased incidence of mucosal candidiasis after HAART initiation: a benign form of immune reconstitution disease?
Nacher M; Vantilcke V; Huber F; Mahamat A; El Guedj M; Randrianjohany A; Clyti E; Aznar C; Carme B; Couppié P
AIDS; 2007 Nov; 21(18):2534-6. PubMed ID: 18025892
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics of highly active antiretroviral therapy-associated immune reconstruction inflammation in acquired immunodeficiency syndrome].
Liu M; Zheng YH; Zhou GQ; Zhou HY; Chen Z; He Y; Chen X; Zheng LW; Jia L; He M
Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):304-8. PubMed ID: 21419003
[TBL] [Abstract][Full Text] [Related]
9. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
[TBL] [Abstract][Full Text] [Related]
11. Correlation between viral load, plasma levels of CD4 - CD8 T lymphocytes and AIDS-related oral diseases: a multicentre study on 30 HIV+ children in the HAART era.
Nesti M; Carli E; Giaquinto C; Rampon O; Nastasio S; Giuca MR
J Biol Regul Homeost Agents; 2012; 26(3):527-37. PubMed ID: 23034272
[TBL] [Abstract][Full Text] [Related]
12. [Leprosy and immune reconstitution syndrome in AIDS].
Aubry P; Bobin P
Bull Soc Pathol Exot; 2008 Feb; 101(1):58-9. PubMed ID: 18432011
[TBL] [Abstract][Full Text] [Related]
13. Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients.
Miziara ID; Weber R
Oral Dis; 2006 Jul; 12(4):402-7. PubMed ID: 16792726
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
[TBL] [Abstract][Full Text] [Related]
15. Immune restoration disease in HIV-infected individuals receiving highly active antiretroviral therapy: clinical and immunological characteristics.
de Boer MG; Kroon FP; Kauffmann RH; Vriesendorp R; Zwinderman K; van Dissel JT
Neth J Med; 2003 Dec; 61(12):408-12. PubMed ID: 15025416
[TBL] [Abstract][Full Text] [Related]
16. Immune reconstitution inflammatory syndrome after highly active antiretroviral therapy: a review.
Tsang CS; Samaranayake LP
Oral Dis; 2010 Apr; 16(3):248-56. PubMed ID: 19758406
[TBL] [Abstract][Full Text] [Related]
17. Increased incidence of leprosy following HAART initiation: a manifestation of the immune reconstitution disease.
Couppié P; Domergue V; Clyti E; El Guedj M; Vaz T; Sainte-Marie D; Marty C; Nacher M
AIDS; 2009 Jul; 23(12):1599-600. PubMed ID: 19487911
[TBL] [Abstract][Full Text] [Related]
18. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
Ortega KL; Vale DA; Magalhães MH
J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
[TBL] [Abstract][Full Text] [Related]
19. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.
Mihăilescu R; Arama V; Paraschiv S; Streinu-Cercel A; Oţelea D; Munteanu D; Iosipenco M; Chiotan C; Benea OE; Mărdărescu M; Rădulescu M; Hristea A; Ungurianu R; Aramă SS; Cercel AS; Călin R; Băicuş C
Rom J Intern Med; 2008; 46(4):305-11. PubMed ID: 19480296
[TBL] [Abstract][Full Text] [Related]
20. Oral lesions in HIV+/AIDS adolescents perinatally infected undergoing HAART.
Gaitán-Cepeda LA; Domínguez-Sánchez A; Pavía-Ruz N; Muñoz-Hernández R; Verdugo-Díaz R; Valles-Medina AM; Meráz-Acosta H
Med Oral Patol Oral Cir Bucal; 2010 Jul; 15(4):e545-50. PubMed ID: 20173726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
